S-23

CAS No. 1010396-29-8

S-23 ( S 23; S23; (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide )

Catalog No. M27332 CAS No. 1010396-29-8

S-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 Get Quote
10MG 58 Get Quote
25MG 115 Get Quote
50MG 177 Get Quote
100MG 290 Get Quote
200MG 430 Get Quote
500MG 695 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    S-23
  • Note
    Research use only, not for human use.
  • Brief Description
    S-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.
  • Description
    S-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.(In Vitro):Administration of 10 nM S-23 induces AR-mediated transcriptional activation in CV-1 cells .(In Vivo):Administration of S-23 to castrated animals increases the weights of the androgen-dependent organ dose-dependently with the ED50s of S-23 in the prostate and levator ani muscle of 0.43 and 0.079 mg/d, respectively.
  • Synonyms
    S 23; S23; (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    PDE3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1010396-29-8
  • Formula Weight
    416.8
  • Molecular Formula
    C18H13ClF4N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@](O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Murray KJ, et al. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. Br J Pharmacol. 1990 Mar;99(3):612-6.
molnova catalog
related products
  • JNJ63576253

    JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).

  • Flutamide

    Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.

  • ARV-110

    ARV-110 is an oral degrader of androgen receptor PROTAC for prostate cancer treatment.